GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circio Holding ASA (OSL:CRNA) » Definitions » Cyclically Adjusted Price-to-FCF

Circio Holding ASA (OSL:CRNA) Cyclically Adjusted Price-to-FCF : (As of Jun. 13, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Circio Holding ASA Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Circio Holding ASA Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Circio Holding ASA's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Circio Holding ASA Cyclically Adjusted Price-to-FCF Chart

Circio Holding ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Circio Holding ASA Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Circio Holding ASA's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Circio Holding ASA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Circio Holding ASA's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Circio Holding ASA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Circio Holding ASA's Cyclically Adjusted Price-to-FCF falls into.



Circio Holding ASA Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Circio Holding ASA's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Circio Holding ASA's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/131.9000*131.9000
=0.000

Current CPI (Dec. 2023) = 131.9000.

Circio Holding ASA Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201309 -11.245 96.400 -15.386
201312 -0.454 96.600 -0.620
201403 -16.156 97.300 -21.901
201406 -0.629 97.500 -0.851
201409 -6.717 98.500 -8.995
201412 -16.870 98.600 -22.567
201503 -21.003 99.200 -27.926
201506 -8.634 100.100 -11.377
201509 -25.699 100.600 -33.695
201512 -29.456 100.900 -38.506
201603 -28.877 102.500 -37.160
201606 -16.717 103.800 -21.243
201609 -11.375 104.200 -14.399
201612 -12.453 104.400 -15.733
201703 -15.309 105.000 -19.231
201706 -18.309 105.800 -22.826
201709 -11.083 105.900 -13.804
201712 -10.969 106.100 -13.636
201803 -14.331 107.300 -17.617
201806 -13.046 108.500 -15.860
201809 -12.505 109.500 -15.063
201812 -11.440 109.800 -13.743
201903 -20.632 110.400 -24.650
201906 -14.027 110.600 -16.728
201909 -11.688 111.100 -13.876
201912 -12.347 111.300 -14.632
202003 -12.263 111.200 -14.546
202006 -9.776 112.100 -11.503
202009 -7.496 112.900 -8.758
202012 -6.003 112.900 -7.013
202103 -8.710 114.600 -10.025
202106 -8.409 115.300 -9.620
202109 -5.668 117.500 -6.363
202112 -6.100 118.900 -6.767
202203 -4.944 119.800 -5.443
202206 -4.252 122.600 -4.575
202209 -4.371 125.600 -4.590
202212 -3.763 125.900 -3.942
202306 0.000 130.400 0.000
202312 0.000 131.900 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Circio Holding ASA  (OSL:CRNA) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Circio Holding ASA Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Circio Holding ASA's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Circio Holding ASA (OSL:CRNA) Business Description

Industry
Traded in Other Exchanges
Address
Vollsveien 19, Lysaker, Oslo, NOR, 1366
Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients.

Circio Holding ASA (OSL:CRNA) Headlines

No Headlines